Alpha Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.99M Sell
3,254
-16
-0.5% -$16.2K 0.43% 67
2025
Q4
$3.51M Buy
3,270
+21
+0.6% +$20.1K 0.5% 63
2025
Q3
$2.48M Buy
3,249
+140
+5% +$104K 0.39% 68
2025
Q2
$2.42M Buy
3,109
+37
+1% +$28.8K 0.42% 67
2025
Q1
$2.54M Sell
3,072
-217
-7% -$181K 0.48% 64
2024
Q4
$2.54M Buy
3,289
+216
+7% +$179K 0.47% 64
2024
Q3
$2.72M Buy
3,073
+2,711
+749% +$2.44M 0.51% 60
2024
Q2
$328K Buy
+362
New +$290K 0.06% 99
2016
Q3
Sell
-31,443
Closed -$2.48M 90
2016
Q2
$2.48M Sell
31,443
-12,533
-28% -$944K 1.78% 18
2016
Q1
$3.17M Buy
43,976
+1,701
+4% +$129K 2.29% 11
2015
Q4
$3.56M Sell
42,275
-9,604
-19% -$797K 2.81% 9
2015
Q3
$4.34M Sell
51,879
-492
-0.9% -$41.5K 3.9% 3
2015
Q2
$4.37M Buy
52,371
+69
+0.1% +$5.26K 3.3% 3
2015
Q1
$3.61M Hold
52,302
2.53% 11
2014
Q4
$3.61M Buy
52,302
+1,252
+2% +$84.5K 2.53% 11
2014
Q3
$3.31M Buy
51,050
+638
+1% +$40.4K 2.6% 13
2014
Q2
$3.13M Buy
+50,412
New +$3.01M 2.25% 16

Other funds holding LLY

Alpha Capital Management's LLY Position: Q1 2026 in Review

Alpha Capital Management reduced its Eli Lilly (LLY) stake by 0.49% in Q1 2026, selling an estimated $16.2K and leaving 3,254 shares worth $2.99M. The position accounts for 0.43% of the portfolio, ranked #67.

Alpha Capital Management first reported a position in LLY in Q2 2014 and has held it in 17 quarters since. The position peaked at $4.37M in Q2 2015. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Alpha Capital Management held 3,254 shares of Eli Lilly worth $2.99M as of Q1 2026.
  • Alpha Capital Management sold 16 Eli Lilly shares in Q1 2026, an estimated $16.2K.
  • Eli Lilly made up 0.43% of Alpha Capital Management's portfolio in Q1 2026, its #67 holding.
  • Alpha Capital Management first reported a position in Eli Lilly in Q2 2014 and has held it in 17 quarters since.
  • Alpha Capital Management's Eli Lilly position peaked at $4.37M in Q2 2015.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Alpha Capital Management's 13F filing for Q1 2026, filed 13 May 2026.